The catch is that only the injection has substantial clinical research behind it
[9] [1] Administered as a once-weekly subcutaneous injection, tirzepatide works through dual incretin receptor activation to enhance insulin secretion in a glucose-dependent manner, suppress glucagon release, slow gastric emptying, and reduce appetite
These medications affect gastric emptying and glucose metabolism , which may pose risks during anaesthesia
Bibcode:2009PNAS..106.9109M
Avsola is indicated for autoimmune conditionsincluding rheumatoid arthritis, rheumatoid factor-positive rheumatoid arthritis, Crohns disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and psoriasisand is administered via intravenous infusion in physician offices or infusion settings
Puede tomarse antes de las sesiones de entrenamiento